MIB-1 proliferative index in parathyroid adenoma & hyperplasia

被引:0
作者
Karak, AK
Sarkar, C
Chumber, S
Tandon, N
机构
[1] ALL INDIA INST MED SCI,DEPT SURG,NEW DELHI 110029,INDIA
[2] ALL INDIA INST MED SCI,DEPT ENDOCRINOL,NEW DELHI 110029,INDIA
关键词
Ki-67; antigen; MBI-1; parathyroid; proliferation index;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A retrospective study on 22 cases of parathyroid adenoma, 9 cases of primary parathyroid hyperplasia and 14 specimens of normal suppressed glandular tissue was undertaken to determine the usefulness of proliferative index (PI) for discriminating adenoma from hyperplasia, as an adjunct to the existing histological criteria. PI was determined by avidin-biotin-complex immunostaining after high temperature microwave antigen retrieval in paraffin sections, using monoclonal MIB-1 antibody which detects paraffin resistant analogue of cell cycle-associated Ki-67 antigen. PI expressed as percentage positive cell nuclei, was 1.36 +/- 0.62 (range 0.04 - 2.72) in adenoma, 1.17 +/- 0.83 (0.02 - 1.98) in hyperplasia and 0.03 +/- 0.02 (0.00 - 0.06) in normal suppressed glandular tissue. While the difference between normal suppressed glandular tissue and adenoma and hyperplasia was significant (P < 0.001), that between adenoma and hyperplasia was not. We conclude that although PI could distinguish between normal suppressed glandular tissue versus glands with primary hyperparathyroidism, it failed as an additional useful parameter for discriminating between adenoma and hyperplasia, both of which have low but similar proliferative activity.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 16 条
[1]   PROLIFERATIVE ACTIVITY IN PARATHYROID TUMORS AS DETECTED BY KI-67 IMMUNOSTAINING [J].
ABBONA, GC ;
PAPOTTI, M ;
GASPARRI, G ;
BUSSOLATI, G .
HUMAN PATHOLOGY, 1995, 26 (02) :135-138
[2]   HISTOLOGIC PARATHYROID ABNORMALITIES IN AN AUTOPSY SERIES [J].
AKERSTROM, G ;
RUDBERG, C ;
GRIMELIUS, L ;
BERGSTROM, R ;
JOHANSSON, H ;
LJUNGHALL, S ;
RASTAD, J .
HUMAN PATHOLOGY, 1986, 17 (05) :520-527
[3]   RELATION BETWEEN CHANGES IN CLINICAL AND HISTOPATHOLOGICAL FEATURES OF PRIMARY HYPERPARATHYROIDISM [J].
AKERSTROM, G ;
BERGSTROM, R ;
GRIMELIUS, L ;
JOHANSSON, H ;
LJUNGHALL, S ;
LUNDSTROM, B ;
PALMER, M ;
RASTAD, J ;
RUDBERG, C .
WORLD JOURNAL OF SURGERY, 1986, 10 (04) :696-702
[4]  
ARNOLD A, 1987, CALCIUM REGULATION B, V9, P39
[5]   FAT STAINING IN PARATHYROID DISEASE - DIAGNOSTIC-VALUE AND IMPACT ON SURGICAL STRATEGY - CLINICOPATHOLOGIC ANALYSIS OF 191 CASES [J].
BONDESON, AG ;
BONDESON, L ;
LJUNGBERG, O ;
TIBBLIN, S .
HUMAN PATHOLOGY, 1985, 16 (12) :1255-1263
[6]   MONOCLONAL-ANTIBODY KI-67 - ITS USE IN HISTOPATHOLOGY [J].
BROWN, DC ;
GATTER, KC .
HISTOPATHOLOGY, 1990, 17 (06) :489-503
[7]  
BRUINING HA, 1971, ROYAL VANGORCUM 1971, V219
[8]   DNA INDEX AND PLOIDY DISTINGUISH NORMAL HUMAN PARATHYROIDS FROM PARATHYROID ADENOMAS AND PRIMARY HYPERPLASTIC PARATHYROIDS [J].
CHRYSSOCHOOS, JT ;
WEBER, CJ ;
COHEN, C ;
MOORE, J ;
DEROSE, PB ;
HAGLER, M ;
BRAY, R ;
STEMPORA, L ;
MAINIERO, M ;
MCGARITY, WC .
SURGERY, 1995, 118 (06) :1041-1050
[9]  
DeLellis RA., 1993, Tumors of the parathyroid gland
[10]  
DERVAN PA, 1992, AM J CLIN PATHOL, V97, pS21